Greenwich Biosciences, Inc.

Registered Principal Details

Business Or Interest:
Pharmaceutical manufacturing and healthcare

Lobbying Interests:
All matters affecting the pharmaceutical manufacturing and healthcare industries

CEO Name:
Justin Gover
Designated Agent for Filer

Contact
JUS
Jennie U Skelton
c/o Politicom Law LLP, 28 Liberty Ship Way, Suite 2815
Sausalito, CA 94965
(415) 903-2800
(415) 610-7604
greenwichbio@politicomlaw.com
http://www.greenwichbiosciences.com

Authorized Lobbyists

Lobbyist Name Exclusive Duties Authorized On Withdrawn On

Lobbying Interests

Legislative Bills/Resolutions

Assembly Bill 206
Assembly Bill 206
Relating to: regulating hemp, providing an exemption from emergency rule procedures, granting rule-making authority, and making an appropriation. (FE)

Bill Text and History

For
Notification Date
5/15/2019
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.
Senate Bill 188
Senate Bill 188
Relating to: regulating hemp, providing an exemption from emergency rule procedures, granting rule-making authority, and making an appropriation. (FE)

Bill Text and History

2019 Wisconsin Act 68

For
Notification Date
5/15/2019
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Administrative Rulemaking Proceedings

Scheduling of FDA approved cannabidiol drugs
Agency Name
Controlled Substances Board (CSB)
Subject
Scheduling of FDA approved cannabidiol drugs
Scope Statement
SS 121_18
For
Notification Date
1/22/2019
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Topics Not Yet Assigned A Bill Or Rule Number

Any legislation or rule that impacts access to Epidiolex or its successor name, or cannabidiol in a drug product approved by the United States Food and Drug Administration.
Development, drafting or introduction of a proposal relating to
Any legislation or rule that impacts access to Epidiolex or its successor name, or cannabidiol in a drug product approved by the United States Food and Drug Administration.

Action Intended To Affect
Both Legislative matter and rule

Notification Date
7/8/2019
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

all matters affecting the regulation and reimbursement of CBD products and the effects on consumers
Development, drafting or introduction of a proposal relating to
all matters affecting the regulation and reimbursement of CBD products and the effects on consumers

Action Intended To Affect
Both Legislative matter and rule

Notification Date
1/11/2019
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Total Lobbying Effort

  2019
January - June
2019
July - December
2020
January - June
2020
July - December
Total
Total Lobbying Expenditures 2019
January - June
$30,483.29
2019
July - December
$27,639.45
2020
January - June
$28,628.28
2020
July - December
$27,000.00
Total $113,751.02
Total Hours Communicating 2019
January - June
23.00
2019
July - December
9.00
2020
January - June
7.00
2020
July - December
0.00
Total 39.00
Total Hours Other 2019
January - June
42.25
2019
July - December
15.75
2020
January - June
24.75
2020
July - December
8.25
Total 91.00

Percent Allocation of Lobbying Effort

Legislative Bills/Resolutions

Relating to: regulating hemp, providing an exemption from emergency rule procedures, granting rule-making authority, and making an appropriation. (FE)
2019
January - June
2019
July - December
2020
January - June
2020
July - December
Total
2019
January - June
15%
2019
July - December
15%
2020
January - June
2020
July - December
Total 11%
Relating to: regulating hemp, providing an exemption from emergency rule procedures, granting rule-making authority, and making an appropriation. (FE)
2019
January - June
2019
July - December
2020
January - June
2020
July - December
Total
2019
January - June
35%
2019
July - December
70%
2020
January - June
2020
July - December
Total 31%

Budget Bill Subjects

No budget bill subjects found.

Administrative Rulemaking Proceedings

2019
January - June
2019
July - December
2020
January - June
2020
July - December
Total
2019
January - June
10%
2019
July - December
2020
January - June
2020
July - December
Total 5%

Topics Not Yet Assigned A Bill Or Rule Number

2019
January - June
2019
July - December
2020
January - June
2020
July - December
Total
2019
January - June
30%
2019
July - December
2020
January - June
2020
July - December
10%
Total 16%
2019
January - June
2019
July - December
2020
January - June
2020
July - December
Total
2019
January - June
2019
July - December
2020
January - June
75%
2020
July - December
Total 18%

Minor Efforts

(Time spent on matters each of which accounted for less than 10% of the organization's lobbying.)

Minor Efforts
2019
January - June
2019
July - December
2020
January - June
2020
July - December
Total
2019
January - June
10%
2019
July - December
5%
2020
January - June
5%
2020
July - December
Total 7%

Other Matters

Includes time spent on:

  • Gubernatorial nominations
  • Matters on which the organization made no lobbying communication

Other Matters
2019
January - June
2019
July - December
2020
January - June
2020
July - December
Total
2019
January - June
2019
July - December
10%
2020
January - June
20%
2020
July - December
90%
Total 13%

Filed Statements of Lobbying Activity and Expenditures